BMS-332 is a dual DGKalpha/zeta lipid kinase inhibitor, with IC50s of 5 and 1 nM against DGKalpha and DGKzeta, respectively. BMS-332 enhances the antigen-specific T cell response. BMS-332 reduces the viral load in the liver and spleen when combined with anti-PD-1 in chronic infection models. BMS-332 can be used for the study of T cell immune checkpoint strategy[1].
Molekulargewicht:
499.55
Reinheit:
99.05
CAS Nummer:
[2407892-15-1]
Formel:
C29H27F2N5O
Target-Kategorie:
DGK
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten